Skyrizi Subcutaneous Injection 360mg Autodoser, containing risankizumab (genetical recombination), is a biologic medication manufactured by AbbVie. It is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and ulcerative colitis, available as a 360mg 2.4mL kit with YJ code 3999450G4027.
Skyrizi Subcutaneous Injection 360mg Autodoser
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →